1. Home
  2. Publications
  3. Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation"

Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation"

Durrani K, Kempen J, Foster S, Group SITED (SITE) R. Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation". Ocul Immunol Inflamm. 2017;:1.
See also: Infectious Disease, October 2017, All, 2017
Last updated on 03/06/2023